换一批
换一批Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.
作者：
主题词
急性病(Acute Disease);青少年(Adolescent);成年人(Adult);年龄因素(Age Factors);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);阿糖胞苷(Cytarabine);用药计划表(Drug Administration Schedule);女(雌)性(Female);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);L-乳酸脱氢酶(L-Lactate Dehydrogenase);白血病, 髓样(Leukemia, Myeloid);白细胞计数(Leukocyte Count);男(雄)性(Male);中年人(Middle Aged);米托蒽醌(Mitoxantrone);多元分析(Multivariate Analysis);骨髓增生异常综合征(Myelodysplastic Syndromes);预后(Prognosis);前瞻性研究(Prospective Studies);缓解诱导(Remission Induction);危险因素(Risk Factors);移植, 自体(Transplantation, Autologous);治疗结果(Treatment Outcome)
DOI
10.1200/JCO.2005.04.5013
PMID
16735702
发布时间
2013-11-21
- 浏览148
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
